263 related articles for article (PubMed ID: 15356785)
1. Long-term interferon-gamma therapy for patients with chronic granulomatous disease.
Marciano BE; Wesley R; De Carlo ES; Anderson VL; Barnhart LA; Darnell D; Malech HL; Gallin JI; Holland SM
Clin Infect Dis; 2004 Sep; 39(5):692-9. PubMed ID: 15356785
[TBL] [Abstract][Full Text] [Related]
2. Itraconazole to prevent fungal infections in chronic granulomatous disease.
Gallin JI; Alling DW; Malech HL; Wesley R; Koziol D; Marciano B; Eisenstein EM; Turner ML; DeCarlo ES; Starling JM; Holland SM
N Engl J Med; 2003 Jun; 348(24):2416-22. PubMed ID: 12802027
[TBL] [Abstract][Full Text] [Related]
3. Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease.
Bemiller LS; Roberts DH; Starko KM; Curnutte JT
Blood Cells Mol Dis; 1995; 21(3):239-47. PubMed ID: 8673477
[TBL] [Abstract][Full Text] [Related]
4. Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study.
Martire B; Rondelli R; Soresina A; Pignata C; Broccoletti T; Finocchi A; Rossi P; Gattorno M; Rabusin M; Azzari C; Dellepiane RM; Pietrogrande MC; Trizzino A; Di Bartolomeo P; Martino S; Carpino L; Cossu F; Locatelli F; Maccario R; Pierani P; Putti MC; Stabile A; Notarangelo LD; Ugazio AG; Plebani A; De Mattia D;
Clin Immunol; 2008 Feb; 126(2):155-64. PubMed ID: 18037347
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease.
Liese J; Kloos S; Jendrossek V; Petropoulou T; Wintergerst U; Notheis G; Gahr M; Belohradsky BH
J Pediatr; 2000 Nov; 137(5):687-93. PubMed ID: 11060536
[TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular effects of recombinant interferon gamma in chronic granulomatous disease.
Newburger PE; Ezekowitz RA
Hematol Oncol Clin North Am; 1988 Jun; 2(2):267-76. PubMed ID: 2839459
[TBL] [Abstract][Full Text] [Related]
7. Increased production of nitric oxide by neutrophils from patients with chronic granulomatous disease on interferon-gamma treatment.
Naderi beni F; Fattahi F; Mirshafiey A; Ansari M; Mohsenzadegan M; Movahedi M; Pourpak Z; Moin M
Int Immunopharmacol; 2012 Apr; 12(4):689-93. PubMed ID: 22330085
[TBL] [Abstract][Full Text] [Related]
8. [The clinical response to interferon-gamma in a patient with chronic granulomatous disease and brain abscesses due to Aspergillus fumigatus].
Touza Rey F; Martínez Vázquez C; Alonso Alonso J; Méndez Piñeiro MJ; Rubianes González M; Crespo Casal M
An Med Interna; 2000 Feb; 17(2):86-7. PubMed ID: 10829464
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human interferon-gamma in patients with chronic granulomatous disease--European follow up study.
Weening RS; Leitz GJ; Seger RA
Eur J Pediatr; 1995 Apr; 154(4):295-8. PubMed ID: 7607280
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease.
International Chronic Granulomatous Disease Cooperative Study Group
N Engl J Med; 1991 Feb; 324(8):509-16. PubMed ID: 1846940
[TBL] [Abstract][Full Text] [Related]
11. Successful interferon gamma therapy in a patient with X-linked chronic granulomatous disease, McLeod syndrome and hyper-IgE. Case report.
Kantar A; Oggiano N; Gabbianelli R; Fabrizzi G; Giorgi PL
Minerva Pediatr; 1994 Apr; 46(4):157-60. PubMed ID: 8084323
[TBL] [Abstract][Full Text] [Related]
12. Recombinant interferon gamma for treatment of chronic granulomatous disease and other disorders.
Bolinger AM; Taeubel MA
Clin Pharm; 1992 Oct; 11(10):834-50; quiz 892-4. PubMed ID: 1341990
[TBL] [Abstract][Full Text] [Related]
13. [Long-term treatment of patients with itraconazole for the prevention of Aspergillus infections in patients with chronic granulomatous disease (CGD)].
Petropoulou T; Liese J; Tintelnot K; Gahr M; Belohradsky BH
Mycoses; 1994; 37 Suppl 2():64-9. PubMed ID: 7609746
[TBL] [Abstract][Full Text] [Related]
14. Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma.
Ezekowitz RA; Dinauer MC; Jaffe HS; Orkin SH; Newburger PE
N Engl J Med; 1988 Jul; 319(3):146-51. PubMed ID: 2838754
[TBL] [Abstract][Full Text] [Related]
15. Nocardia infection in chronic granulomatous disease.
Dorman SE; Guide SV; Conville PS; DeCarlo ES; Malech HL; Gallin JI; Witebsky FG; Holland SM
Clin Infect Dis; 2002 Aug; 35(4):390-4. PubMed ID: 12145721
[TBL] [Abstract][Full Text] [Related]
16. [Biological properties and clinical applications of interferon gamma (IFN-gamma)].
Robak T
Acta Haematol Pol; 1994; 25(1):19-29. PubMed ID: 8209610
[TBL] [Abstract][Full Text] [Related]
17. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ;
Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703
[TBL] [Abstract][Full Text] [Related]
18. Effects of exogenous interferon gamma on patients with treatment-resistant chronic rhinosinusitis and dysregulated interferon gamma production: a pilot study.
Jyonouchi H; Sun S; Kelly A; Rimell FL
Arch Otolaryngol Head Neck Surg; 2003 May; 129(5):563-9. PubMed ID: 12759271
[TBL] [Abstract][Full Text] [Related]
19. Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome.
Haab F; Cardozo L; Chapple C; Ridder AM;
Eur Urol; 2005 Mar; 47(3):376-84. PubMed ID: 15716204
[TBL] [Abstract][Full Text] [Related]
20. A case of invasive aspergillosis in CGD patient successfully treated with Amphotericin B and INF-gamma.
Mamishi S; Zomorodian K; Saadat F; Gerami-Shoar M; Tarazooie B; Siadati SA
Ann Clin Microbiol Antimicrob; 2005 Mar; 4():4. PubMed ID: 15745454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
